Angela O'Neill

67 POSTS 0 COMMENTS

Admedus sells CardioCel and VacsuCel to focus on TAVI

Admedus has sold the distribution rights to its CardioCel and VascuCel product range for $A36.2 million to US-based LeMaitre Vascular. A press release from...

Penumbra announces enrolment of first patient in study of mechanical power...

Penumbra has announced the enrolment of the first patient into the CHEETAH study, a prospective, multicentre US study to evaluate the safety and performance...

Douglas Drachman named as next vice chair of American College of...

Douglas Drachman has been selected as the next vice chair of the American College of Cardiology’s Annual Scientific Session. Drachman will serve as vice...

Abiomed announces PROTECT III clinical data for protected PCI with Impella

Abiomed has announced the results of PROTECT III, an ongoing, prospective, single-arm US Food and Drug Administration (FDA) post-market approval (PMA) study for Impella...

AccuCinch ventricular repair system associated with favourable safety profile at 30...

Data from an interim analysis of heart failure patients treated in the CorCinch FMR study show, a press release reports, that the AccuCinch ventricular...

TCT 2019: Apixaban plus a P2Y12 inhibitor is the optimal strategy...

A prespecified analysis of data from the AUGUSTUS study, released at late-breaking session at the Transcatheter Cardiovascular Therapeutics scientific symposium (TCT 2019; 25–29 September,...

CE mark granted to the Gore Cardioform ASD Occluder for the...

The Gore Cardioform Occluder for atrial septal defects (ASD) has received CE mark in Europe, the company has announced, stating that the move was...

Transseptal puncture techniques must be mastered if physicians wish to perform...

Interest in transseptal puncture has surged with the development of structural interventions for the left side of the heart. Francesco Maisano provides an update...

Endotronix closes expanded series D financing round of US$70 million for...

Endotronix has announced the expansion of its series D financing round, bringing the total to US$70 million. The expansion syndicate includes new investment from...

TCT 2019: Resolute Onyx noninferior to BioFreedom in high bleeding risk...

ONYX ONE, the first randomised trial to compare a durable polymer drug-eluting stent to a polymer-free drug-coated stent in patients at high risk of...

TCT 2019: PARTNER 3 substudy finds TAVI has sustained health status...

A subanalysis of PARTNER 3 quality of life data found a modest, but significant, improvement in one-year disease-specific quality of life after transcatheter aortic...

TCT 2019: Benefits of complete revascularisation continue to accumulate over the...

A timing substudy of the COMPLETE trial has found that, compared with culprit-lesion only percutaneous coronary intervention (PCI), a strategy of non-culprit lesion PCI...

TCT 2019: COAPT finds MitraClip safety and efficacy is maintained at...

The MitraClip device (Abbott) continues to demonstrate safety and efficacy at three years in patients with heart failure and secondary mitral regurgitation (MR), findings...

TCT 2019: Acurate neo does not meet non-inferiority compared to Sapien...

The first randomised trial to compare the safety and efficacy of the Acurate neo transcatheter heart valve (Boston Scientific) with the Sapien 3 TAVI...

TCT 2019: Safety and efficacy of Portico valve noninferior to FDA-approved...

The Portico IDE study has found that 30-day safety and one-year effectiveness outcomes of a novel self-expanding transcatheter aortic valve implantation (TAVI) system for...

TCT 2019:Aspirin withdrawal after three months of dual antiplatelet therapy reduces...

Data from the TWILIGHT study demonstrate that, compared to ticagrelor plus aspirin, ticagrelor monotherapy reduces bleeding events without increasing the risk of death, myocardial...

No device-related mortality at one year for India’s first trancatheter heart...

Ashok Seth (New Delhi, India) talks to BLearning at EuroPCR 2019 (21–24 May, Paris, France) about the MyVal-1 study which looked at the one-year clinical outcomes of India’s first...

Boston Scientific announces schedule of presentations at TCT 2019

Boston Scientific has announced the key data that will be presented at the Transcatheter Cardiovascular Therapeutics conference (TCT 2019; 25–29 September, San Francisco, USA). Data...

Corindus showcasing CorPath GRX system at TCT 2019

Corindus Is to showcase the CorPath GRX system at the Transcatheter Cardiovascular Therapeutics Conference (TCT 2019; 25–29 September, San Francisco, USA). CorPath GRX is...

Abbott starts trial to evaluate TriClip for percutaneous repair of tricuspid...

Abbott has announced its TRILUMINATE pivotal trial to evaluate the safety and effectiveness of the TriClip transcatheter tricuspid valve repair system for the treatment...

ESC 2019: Complete revascularisation superior to culprit lesion-only PCI in STEMI...

complete-revascularisation
A strategy of complete revascularisation was superior to culprit lesion-only percutaneous coronary intervention (PCI) in reducing the risk of cardiovascular death or myocardial infarction...

ECHSA 2019: CardioCel acellular bioscaffold handles well

Caner Salih (London, UK) talks to Cardiovascular News about the CardioCel bioscaffold (Admedus) and the benefits it has brought to his practice at Guy's...

Age alone should not preclude TAVI in patients aged ≥90 years

The clinical frailty score currently used to assess suitability for transcatheter aortic valve implantation (TAVI) requires further refinement, a study published in the American...

Unfilled prescriptions for PCSK9 inhibitors lead to higher rates of cardiovascular...

Patients whose prescription for PCSK9 inhibitors (proprotein convertase subtilisin kexin type 9 inhibitors) are either unfilled or rejected by insurance companies have a higher...

The findings on transcatheter aortic valve implantation in patients who are...

Recent low-risk trials for TAVI look set to expand its indications for use. Amar Krishnaswamy and Samir Kapadia assess the impact of the findings...

Medtronic enters into AI partnership for stroke care

Medtronic has entered into a partnership agreement with Viz.ai to accelerate the adoption of artificial intelligence software for stroke prevention and treatment in US...

TARGET BP I trial enrols its first patient

The first patient has been randomised in the TARGET BP I trial at the Piedmont Heart Institute in Atlanta, USA, to investigate the use...

Women with idiopathic intracranial hypertension at twice the risk of cardiovascular...

Women who suffer from idiopathic intracranial hypertension (IIH) have twice the risk of heart conditions and stroke than those of the same age and...

SAVR has lower mortality and MACCE than TAVI using first-generation devices...

Five-year results suggest that surgical aortic valve replacement (SAVR) is associated with lower rates of mortality and major adverse cardiac and cerebrovascular events (MACCE)...

The influence of technology and robotics in the catheterisation laboratory is...

Thanks to the use of robotics in healthcare, many procedures that were once highly invasive are now being performed using minimally invasive techniques, with...

Carillon Mitral Contour System reaches 1,000 implants for functional mitral regurgitation

  Cardiac Dimensions has announced in a press release that its Carillon Mitral Contour System has now been implanted in 1,000 patients in the USA,...

Medtronic announces global registry of HVAD thoracotomy implants

  Medtronic has announced plans for a global registry of its HeartWare HVAD System, following the release of two-year outcomes from the LATERAL clinical trial....

FEops HEARTguide wins CSI Highlight of the Year Award

FEops has won the CSI Frankfurt 2019’s Highlight of the Year Award for its FEops HEARTguide under the category of interventional imaging. A press...

New Liverpool Centre for Cardiovascular Science established

The Liverpool Centre for Cardiovascular Science, an alliance between academia and the NHS, was established to advance cardiovascular and stroke research and innovation locally,...

MeRes100 BRS demonstrates sustained safety and efficacy

Data from the MeRes-1 and MeRes-1 Extend clinical trials, released at EuroPCR 2019 (20–24 May, Paris, France), demonstrate sustained efficacy and safety for the...

Admedus’ announces favourable five-year outcomes for its CardioCel bioscaffold

Admedus has announced positive data from an independent study into the performance of its tissue engineered bovine pericardial implant CardioCel, which is used in...

PASCAL poised to rival MitraClip for safety and efficacy

PASCAL’s (Edwards Lifesciences) safety and efficacy may rival that of MitraClip (Abbott) for the treatment of mitral regurgitation (MR), according to data published in...

NICE issues recommendations on insertion of cerebral protection devices during TAVI

The National Institute for Health and Care Excellence (NICE) has released evidence-based recommendations on the percutaneous insertion of a cerebral protection device to prevent...

The evolution of PCR: milestones and achievements in its 30-year journey

2019 saw the 30th anniversary of EuroPCR, with 11,206 participants gathering in Paris. William Wijns, PCR chair, shares his perspective on how it has...

SCAI document provides advice on cath labs’ financial viability

The Society for Coronary Angiography (SCAI) has issued a statement, endorsed by the Alliance of Cardiovascular Professionals (ACVP), providing advice on the economics of...

Cardiologists can help to avert nuclear doomsday

Cardiologists can help to reduce the threat of nuclear war and move “the hands of the Doomsday Clock back from the midnight hour”, according...

PCR statement on TAVI signals “paradigm shift” in treatment of severe...

Evolving indications for the use of transcatheter aortic valve implantation (TAVI) have led to a series of “paradigm shifts” in the treatment of severe...

Early treatment with Helix system improves ejection fraction and symptoms

The Helix biotherapeutic delivery system (Biocardia), which delivers cell therapy to patients within four weeks of a heart attack, led to improved ejection fraction...

Biotronik announces positive data for Magmaris

A press release from Biotronik highlights data from the BIOSOLVE-IV registry outlining procedural success and a positive safety profile at one year for its...

FDA approves Cardioform ASD Occluder for the treatment of atrial septal...

The Cardioform ASD Occluder (Gore Medical) has received US Food and Drug Administration (FDA) premarket approval (PMA) for use in the percutaneous closure of...

EuroPCR 2019: Ultrasound pulmonary artery denervation “improving patient outcomes”

TROPHY1
Alex Rothman (Sheffield, UK) discusses the TROPHY1 study which looked at the safety and efficacy of ultrasound pulmonary artery denervation in patients with pulmonary...

American College of Cardiology names its first director of diversity and...

The American College of Cardiology (ACC) has announced the appointment of Ranna Parekh as its first director of diversity and inclusion. Parekh will work...

EuroPCR 2019: PARTNER 3 results “disruptive to our practice”

Thomas Modine (Lille, France) talks to Cardiovascular News about the PARTNER 3 trial comparing low-risk patients who had a transcatheter aortic valve replacement (TAVR)...

EuroPCR 2019: VIVALL pilot study shows promise for safe use of...

Early experience with the Allegra transcatheter heart valve (New Valve Technology) suggests it is safe for use in patients who have clinically significant degenerated...

EuroPCR 2019; TRILUMINATE suggests TriClip is safe and effective

Use of a TriClip (Abbott) for edge-to-edge repair in patients with tricuspid regurgitation appears to be a safe procedure, according to 30-day data from...

EuroPCR 2019: PCR issues statement on edge-to-edge repair in heart failure...

PCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) issued a statement at EuroPCR 2019 (20–24 May, Paris, France) outlining the role of...

EuroPCR 2019: Consensus paper on intracoronary imaging focuses on acute coronary...

A consensus paper on the use of intracoronary imaging was released at EuroPCR 2019 (20–24 May, Paris, France) as a joint document with the...

Diagnosing coronary stenosis with diastolic pressure ratio measurements is equivalent to...

Using the diastolic pressure ratio (dPR) to identify ischaemia-producing lesions in patients with coronary artery disease provides a similar diagnostic performance to the instantaneous...

ClearFlow announces positive trial results and inclusion in ERAS guideline recommendations...

ClearFlow medical device company has announced positive clinical trial results for its PleuraFlow device, presented at the American Association for Thoracic Surgery (AATS) 99th...

USA needs to put greater emphasis on home-based cardiac rehabilitation

A Scientific Statement from the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology has called...

Keith Dawkins appointed as chief medical officer at Shockwave Medical

Shockwave Medical has appointed Keith D Dawkins as its chief medical officer. In a press release from the company, Dawkins states: “Given the challenges...

Avance steerable introducer given FDA 510(k) clearance

The AVANCE steerable introducer product family (BioCardia) has received US Food and Drug Administration (FDA) 510(k) clearance. The AVANCE device is designed to introduce...

Cordis expands its interventional cardiology portfolio with full US launch of...

Cordis, a Cardinal Health company, has announced the full US launch of its Radial 360 portfolio, offering a complete range of products to facilitate...

FDA approves extended duration of use for Impella 5.0 and Impella...

Abiomed has announced an expanded US Food and Drug Administration (FDA) approval for the Impella 5.0 and Impella LD heart pumps premarket approval (PMA)...

Virtue SEB given breakthrough device designation by FDA

The Virtue (Orchestra BioMed) sirolimus-eluting balloon for the treatment of coronary in-stent restenosis has secured breakthrough device designation from the US Food and Drug...

Bardy Diagnostics announces $35.5M funding injection

Bardy Diagnostics, provider of ambulatory cardiac monitoring technologies and custom data solutions, has announced it has raised $35.5 million (US) in Series B funding,...

ACC 2019: Less bleeding with one-month DAPT than standard therapy, with...

One-month dual antiplatelet therapy (DAPT) followed by 12 months of clopidogrel monotherapy leads to a greater reduction in bleeding events following percutaneous coronary intervention...

RADIANCE SOLO HTN finds greater blood pressure drop after renal denervation

Six-month "on-medication" results from the RADIANCE-HTN SOLO clinical trial have found that patients treated with the Paradise ultrasound denervation system (ReCor Medical Inc.) were...

Alirocumab receives EC approval in established atherosclerotic cardiovascular disease

The European Commission (EC) has approved the use of alirocumab (Praluent, Sanofi), a PCSK9 inhibitor, in adults with established atherosclerotic cardiovascular disease (ASCVD) to...

Richard Kovacs assumes presidency of the American College of Cardiology

Richard Kovacs has become the new president of the American College of Cardiology (ACC). He officially assumed his role during the convocation ceremony held...

2 Heart Research UK funds UCL research to improve baby congenital...

National charity, Heart Research UK has granted funding for an innovative research project with University College London, UK, and Great Ormond Street Hospital, London,...

AHA 2016: Elizabeth M McNally wins AHA prize for research into...

The American Heart Association (AHA) awarded its Basic Research Prize for 2016 to Elizabeth M McNally (Chicago, USA) for “Ground-breaking investigations of novel genetic...